Dimed SA Distribuidora de Medicamentos banner

Dimed SA Distribuidora de Medicamentos
BOVESPA:PNVL3

Watchlist Manager
Dimed SA Distribuidora de Medicamentos Logo
Dimed SA Distribuidora de Medicamentos
BOVESPA:PNVL3
Watchlist
Price: 14.57 BRL -0.27% Market Closed
Market Cap: R$2.2B

Dimed SA Distribuidora de Medicamentos
Investor Relations

Dimed SA Distribuidora de Medicamentos engages in the marketing, distribution and sale of medicines and cosmetics. The company is headquartered in Eldorado Do Sul, Rio Grande Do Sul and currently employs 9,414 full-time employees. The Company, along with its subsidiaries, sells, distributes, imports, exports and produces a variety of products, including drugs, perfumes, cosmetics, dermo-cosmetics, personal care products, dietary supplements, and fitness, orthopedic and physiotherapy accessories. The company organizes its business into two main segments: Medicine and Perfumery. The firm provides retail and wholesale distribution. The firm owns distribution centers in Brazilian states of Rio Grande do Sul, Santa Catarina, Parana, Goias and Espirito Santo, as well as over 280 stores in states of Rio Grande do Sul, Santa Catarina and Parana.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q1 2025
Call Date
May 14, 2025
AI Summary
Q1 2025

Strong Sales Growth: Grupo Panvel grew sales by 15.9% in Q1 2025, despite facing a challenging market and unfavorable calendar effects.

Margin Stability: Retail gross margin stayed healthy at 29.4%, supported by pricing discipline, private label expansion, and supplier negotiations.

Market Share Gains: The company recorded its 20th consecutive quarter of market share growth, notably gaining almost 1% share in Santa Catarina and surpassing 1% in São Paulo city.

Private Label Strength: Panvel's own brand products now represent 7.8% of sales, with strong growth and further expansion targeted.

Digital & Delivery Expansion: Digital sales and delivery services continued to grow, with a focus on balancing online and offline channels for customer convenience.

Positive Free Cash Flow: Panvel generated over BRL 14 million in free cash flow, reversing the usual Q1 cash burn seen in prior years.

Optimistic Outlook: Management expects ongoing sales momentum, margin resilience, and further EBITDA and net income margin expansion in the coming quarters.

Key Financials
Sales Growth
15.9%
Retail Gross Margin
29.4%
EBITDA
BRL 64.6 million
Free Cash Flow
over BRL 14 million
Average Sale per Store
BRL 705,000
Number of Stores
639
Private Label Share of Sales
7.8%
Net Debt to EBITDA
1.2x
Other Earnings Calls

Management

Mr. Julio Ricardo Mottin Neto Neto
Chief Executive Officer
No Bio Available
Mr. Antônio Carlos Tocchetto Napp
CFO & Investor Relations Officer
No Bio Available
Mr. Roberto Coimbra Santos
Executive Officer, MD & Director
No Bio Available
Sergio Rigon
Controller
No Bio Available

Contacts

Address
RIO GRANDE DO SUL
Eldorado do Sul
Avenida Industrial Belgraff, 865, Predio 100, Industrial
Contacts
+555134819677
www.panvel.com.br
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett